| Financial Year |
March 31 2023 |
| Monetary Funds |
533,312,112.83 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
224,958,564.85 |
| Advances to Suppliers |
22,157,849.14 |
| Other Receivables |
972,277,636.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
563,546,686.97 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
25,781,502.88 |
| Total Current Assets |
4,813,447,337.43 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
1,155,225,066.99 |
| Long-term Equity Investment |
599,359,357.88 |
| Investment Properties |
3,199,321,400.00 |
| Fixed Assetes |
1,215,620,158.99 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,359,950.14 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
48,058,430.78 |
| Deferred Income Tax Assets |
254,879,946.31 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
7,953,932,715.19 |
| Total Assets |
12,767,380,052.62 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
441,042,487.94 |
| Accounts Received In Advance |
69,423,996.03 |
| Employee Compensation Payable |
83,854,664.41 |
| Taxes Payable |
381,992,717.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,418,479,239.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
378,847,182.27 |
| Other Current Liabilities |
25,083,034.53 |
| Sub-Total of Current Liabilities |
4,832,035,990.95 |
| Long-term Loans |
3,184,449,348.48 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
225,227,262.92 |
| Special Payable |
-- |
| Estimatied Liabilities |
274,626,307.46 |
| Deferred Income Tax Liabilities |
515,826,182.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,358,257,566.76 |
| Total Liabilities |
10,190,293,557.71 |
| Paid-In Capital(Or Share Stock) |
1,605,686,909.00 |
| Capital Surplus |
4,641,827,677.21 |
| Surplus Reserve |
266,449,114.23 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-4,925,390,886.70 |
| Minority Stockholder's Interest |
954,221,405.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,622,865,089.22 |
| Owner's Equity（Stockholder's Equity） |
2,577,086,494.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,767,380,052.62 |
